Navigation Links
Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
Date:12/30/2012

New York, New York (PRWEB) December 30, 2012

Propecia lawsuits alleging use of the drug caused men to suffer persistent sexual side effects continue to move forward in a consolidated litigation now underway in New Jersey Superior Court, Middlesex County. According to court records, 248 claims are pending in the New Jersey Propecia litigation, and the proceeding’s next Status Conference is scheduled for January 10, 2013. (In Re: Propecia Litigation – No. 623, N.J. Sup. Ct.).

“We continue to hear from men who have allegedly suffered persistent sexual dysfunction long after they stopped taking Propecia. We look forward to this litigation, as well as the federal litigation, moving forward in the coming year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The firm is currently offering free lawsuit reviews to alleged victims of Propecia sexual side effects.

Propecia Sexual Side Effects
Propecia is a prescription medicine that is used to treat male pattern baldness that has recently been linked to sexual dysfunction in men. In April 2012, the U.S. Food & Drug Administration (FDA) announced that the Propecia label would be updated to advise that some men had experienced persistent sexual dysfunction, including problems with libido, ejaculation and orgasm, long after their use of the drug had ended.*

Since the FDA announcement, additional research has confirmed an association between Propecia and male sexual dysfunction. For example, a July 2012 study in the Journal of Sexual Medicine found that such problems may last months after patients stop using the drug.** A survey of men who suffered Propecia sexual side effects published in the Journal of Clinical Psychiatry in August 2012 found that 75 percent report
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Lawsuit on Propecia: Severe Adverse Events
2. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
3. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
4. Nexium MDL Consolidated for Bone Fracture Lawsuits: AttorneyOne Informs
5. DrugRisk Announces Updated Information on Mirena Lawsuits
6. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
7. Dr. Farshchian: Subacromion Bursitis is Now being Treated with Cell Therapy
8. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
9. Dr. Farshchian: Rotator Cuff Injuries are being Treated Now Using Cell Therapy at the Center for Regenerative Medicine
10. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
11. TMAIDA PR Announces that CHEW Owner, a Chicago Wellness Company is Being Recognized as a "Diva" by Chicago Publicist/Socialite Owner of Maven Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... West Orange, NJ (PRWEB) , ... July 31, ... ... of obstructive sleep apnea (OSA) and the growing number of individuals who remain ... millions of Americans continue to shy away from traditional CPAP therapy due to ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce Human Error ... **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 – Raleigh, ... helping drug, biologic and device firms reduce manufacturing errors by 50 percent or ...
(Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the next generation ... community members to contribute to the College’s “My Brother’s Keeper Scholarship.” The President’s signature ... stay on track. Providing the support they need to think more broadly about their ...
(Date:7/30/2015)... Austin, Texas (PRWEB) , ... July 30, 2015 ... ... Critical Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that ... Dyslipidemia have been published for use on the CDISC website . These ...
(Date:7/30/2015)... ... ... connection between a healthy head of hair and a feeling of confidence is a powerful ... can have a devastating impact on the daily life of a person. From increased ... of hair loss are not to be taken lightly. , The skilled staff at Parsa ...
Breaking Medicine News(10 mins):Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2
... for Public-Private Partnerships at The Henry M. Jackson Foundation ... to announce the recipients of the 2012 Heroes of ... excellence and selfless dedication to advancing medicine for our ... their families. The recipients will be honored at the ...
... 6, 2012 Discoveries made in the laboratories of ... the first time, advance to the clinical research stage ... Translational Research Institute for Metabolism and Diabetes (TRI). The ... in the brain, which appears to resolve obesity without ...
... MONDAY, March 5 (HealthDay News) -- New guidelines for colorectal ... the emphasis on individual risk. People at average risk ... 50, whereas people at high risk -- those with inflammatory ... disease -- should get screened starting at age 40 or ...
... Doctors are more likely to order imaging and other diagnostic ... to the test results, according to a new study. ... efficiency, researchers from Harvard Medical School found easy access to ... percent increase in imaging test orders. Computerization actually could be ...
... today issued a new guidance statement for colorectal cancer ... cancer-related deaths for men and women in the United ... in the March 6 issue of Annals of ... this guidance statement to present information to physicians and ...
... March 5 (HealthDay News) -- Patients suffering from advanced ... physicians, so everyone is on the same page with ... The advice is outlined in a "scientific statement" ... "For patients with advanced heart failure, the decision-making ...
Cached Medicine News:Health News:HJF Center announces Heroes of Military Medicine award recipients 2Health News:Sanford-Burnham research advances to patient studies at TRI 2Health News:Sanford-Burnham research advances to patient studies at TRI 3Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 3Health News:Computerization May Not Curb Medical Tests, Costs 2Health News:American College of Physicians releases new colorectal cancer screening guidance statement 2Health News:Heart Failure Patients Urged to Discuss Care With Docs 2
(Date:7/30/2015)... (NYSE: RMD ) today announced results for its ... was $453.1 million, a 9 percent increase compared with ... increase on a constant currency basis).  Net income was ... 2014.  Diluted earnings per share for the quarter were ... The results for the quarter ended ...
(Date:7/30/2015)... we bring you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. ... Medicare resources and continue highlighting the success of the prescription drug benefit, commonly referred ... out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... OAKS, Calif., July 30, 2015  Amgen (NASDAQ: ... the second quarter of 2015. Key results include: ... the second quarter of 2014 to $5,370 million, ... by Enbrel ® (etanercept), Prolia ® ... (carfilzomib) and XGEVA ® (denosumab). Unfavorable changes ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19
... Texas, Feb. 23, 2012   ULURU Inc. (NYSE ... Goods Certificate has been issued by the Therapeutic Goods ... Commenting on the approval in Australia, Kerry P. ... another important milestone in the worldwide commercialization of Altrazeal®.  ...
... Feb. 23, 2012 A new imaging efficiency ... Medicaid Services (CMS) to reduce CT scans in ... are performing CT scans inappropriately, according to a ... of Emergency Medicine ("Assessment of Medicare,s Imaging ...
Cached Medicine Technology:ULURU Inc. Announces Approval to Market Altrazeal® in Australia 2ULURU Inc. Announces Approval to Market Altrazeal® in Australia 3Government Rule Designed to Limit CT Scans in ERs Is Unreliable, Invalid and Inaccurate, Says ACEP 2
... F 265 is a highly accurate portable, waterproof ... temperature measurements. Temperature compensated pH results can be ... or a 3-in-1 electrode. • This GLP/GMP compliant ... a printer or a computer. Up to 100 ...
... Over-sized compressor. Triple pane thermal glass. ... System No plumbing required. Equipped with a ... on Parts & Labor and an Additional 4 ... as a chromatography unit which includes two access ...
... 3 slide doors, 12 shelves.Over-sized compressor. Triple ... interior lighting. Self-Contained System No plumbing required. ... Full One Year Warranty on Parts & Labor ... Also available as a chromatography unit ...
... 1 swing door 4 shelves. Over-sized ... doors. Fluorescent interior lighting. Self-Contained System ... foot cord. Full One Year Warranty on ... Warranty on Compressor. Also available as ...
Medicine Products: